Details for: FORMULA F L W


Product description

Product name: FORMULA F L W

Company name: CREATIVE NUTRITION CANADA CORP.

DIN: 00610151

Status: Cancelled Post Market

Status date: 1997-01-20

Active ingredient(s) Strength
ASCORBIC ACID 320 MG / TAB
BIOTIN 10 MCG / TAB
CALCIUM ASCORBATE 80 MG / TAB
CHOLINE BITARTRATE 72.5 MG / TAB
CHROMIUM (CHROMIUM TRIOXIDE) 20 MCG / TAB
D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 50 MG / TAB
FOLIC ACID .04 MG / TAB
INOSITOL 4 MG / TAB
MAGNESIUM (MAGNESIUM OXIDE) 40 MG / TAB
MANGANESE (MANGANESE GLUCONATE) .5 MG / TAB
NICOTINAMIDE 5 MG / TAB
NICOTINIC ACID 5 MG / TAB
POTASSIUM (POTASSIUM CHLORIDE) 20 MG / TAB
POTASSIUM (POTASSIUM CITRATE) 20 MG / TAB
SELENIUM (SODIUM SELENITE) 25 MCG / TAB
VITAMIN A (FISH LIVER OIL) 4000 UNIT / TAB
VITAMIN B12 (VITAMIN B12) 25 MCG / TAB
VITAMIN B1 (THIAMINE HYDROCHLORIDE) 20 MG / TAB
VITAMIN B2 5 MG / TAB
VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 15 MG / TAB
VITAMIN E (D-ALPHA TOCOPHEROL) 65 UNIT / TAB
ZINC (ZINC GLUCONATE) 3 MG / TAB

Resources

Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.

For consumers
Resource Description
Report a side effect

Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine.

All suspected side effects should be reported, especially those that are:

  • Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or
  • Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death;
  • Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.

For health care professionals
Resource Description
Report a serious adverse drug reaction (for hospitals)

Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital.

This regulatory requirement only applies to hospitals.

For researchers
Resource Description
Search Clinical Information After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.
All resources
Resource Description
Search Clinical Information After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.
Report a side effect

Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine.

All suspected side effects should be reported, especially those that are:

  • Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or
  • Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death;
  • Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.

Report a serious adverse drug reaction (for hospitals)

Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital.

This regulatory requirement only applies to hospitals.

Resource Description
Report a side effect

Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine.

All suspected side effects should be reported, especially those that are:

  • Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or
  • Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death;
  • Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.